Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2025)

Maravai Lifesciences Holdings has reported Times Interest Earned over the past 6 years, most recently at -$8.97 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$8.97 for Q4 2025, down 167.95% from a year ago — trailing twelve months through Dec 2025 was -$7.98 (down 61.46% YoY), and the annual figure for FY2025 was -$7.98, down 61.46%.
  • Times Interest Earned for Q4 2025 was -$8.97 at Maravai Lifesciences Holdings, down from -$6.0 in the prior quarter.
  • Over the last five years, Times Interest Earned for MRVI hit a ceiling of $62.83 in Q1 2022 and a floor of -$12.15 in Q3 2024.
  • Median Times Interest Earned over the past 5 years was -$0.8 (2024), compared with a mean of $8.59.
  • Biggest five-year swings in Times Interest Earned: soared 1744.85% in 2021 and later tumbled 911.03% in 2024.
  • Maravai Lifesciences Holdings' Times Interest Earned stood at $22.01 in 2021, then plummeted by 51.24% to $10.73 in 2022, then crashed by 104.33% to -$0.46 in 2023, then tumbled by 620.98% to -$3.35 in 2024, then plummeted by 167.95% to -$8.97 in 2025.
  • The last three reported values for Times Interest Earned were -$8.97 (Q4 2025), -$6.0 (Q3 2025), and -$9.73 (Q2 2025) per Business Quant data.